funding

NeuroBell secures €2.1m to launch device that detects seizures in babies

UCC spin-out currently seeking FDA approval for its pocked-sized device with an intention to launch the solution commercially in 2025 at the latest

NeuroBell founders: Dr Mark O’Sullivan, Colm Murphy and Dr Alison O’Shea